Navigation Links
TVM Capital Group Announces Two-pronged Global Investment Strategy with Renewed MENA Focus
Date:11/5/2013

DUBAI, UAE, November 5, 2013 /PRNewswire/ --



During BioEurope Conference in Vienna, TVM Capital clarifies its international set up and investment strategy: two independent investment teams to focus on Healthcare Private Equity investments in the MENA region and Life Science Venture Capital investments in Western Europe and North America.

TVM Capital, who has long been a leading international investment firm, announced that it will sharpen its investment focus and exclusively invest in innovative healthcare delivery, pharmaceutical and medical device companies through its private equity team TVM Capital MENA, based in Dubai, and finance innovation in biopharmaceuticals and medical technologies through its venture capital team, based in Munich and Montreal.

Dr. Helmut Schühsler, Chairman of TVM Capital comments: "We experience a significant opportunity through the rapid ascension of emerging markets and the MENA region is becoming an attractive investment geography for private equity investment into private healthcare. At the same time, the market for biotechnology company financings has proved to be difficult, with the public market seeing a tremendous surge in interest and public financings being the most important contribution to the industry's well-being in 2013. In our 30-year history we have lived through several bull and bear markets in our target industries and have managed to adjust our strategy and to change the way we do business. What has never changed though is our unwavering focus on innovation and quality. I am personally proud of the evolution of our firm into a global investment house with a clear focus on innovation for patients. Bringing innovative solutions to the healthcare market also comes
'/>"/>

SOURCE TVM Capital MENA
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
2. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
3. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
4. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
5. Generex Secures Commitments for $3.6M Capital Raise
6. Life Technologies to Present at Barclays Capital Global Healthcare Conference
7. WestPark Capitals Michael Wechsler Comments on the Life Insurance Market
8. PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
9. SeraCare Shareholders Approve Acquisition by Linden Capital Partners
10. Trovagene, Inc. Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.
11. Foundation Venture Capital Group Makes Eighth Start-Up Investment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 24, 2014  Vermillion, Inc. (Nasdaq:   VRML), ... announced today that the Company closed its previously ... Management, Jack W. Schuler , Birchview Fund ... $10.5 million, before offering expenses.  The proceeds will ...
(Date:12/24/2014)... “Preparative & Process Chromatography Market by ... Solvents, Buffers, Valves, Guages, Seals), Accessories, Services, End ... to 2019” provides a detailed overview of the ... and strategies impacting the preparative and process chromatography ...
(Date:12/24/2014)... Boston, MA (PRWEB) December 23, 2014 Earlier ... James L. Sherley, director of the Adult Stem Cell Technology ... overlooked and under appreciated unique property of adult tissue stem ... Misunderstood in the Past, Important for the Future,” embodied the ...
(Date:12/24/2014)... Bethesda, MD (PRWEB) December 23, 2014 ... law H.R. 83, the Omnibus and Continuing Resolution Appropriations ... hydrocephalus a condition eligible to receive funding through the ... Department of Defense (DoD). The Hydrocephalus Association (HA), working ...
Breaking Biology Technology:Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2
... CLEVELAND, June 22, 2011 Clinical Research Management, ... in basic and applied research, clinical trials, and ... a new, 5-year, $97MM research support contract titled ... (SMMRS) to be performed at the Walter Reed ...
... June 22, 2011 ,   ... a novel platform technology for the oral delivery of ... Berelowitz, M.D., has been appointed the Chairman of its,Scientific ... Board of Directors in May 2010,and will now expand ...
... Biodesign, a drug discovery company that utilizes ultra-high throughput ... therapeutic agents against its novel disease-based targets, or its ... medicinal chemistry space at 8 Black Forest Road in ... 11,000 square feet of state-of-the-art research laboratories and office ...
Cached Biology Technology:ClinicalRM (formerly CRM) Awarded $97MM U.S. Army Contract to Support Military Clinical Research for the Warfighter 2Oramed Pharmaceuticals Appoints Dr. Michael Berelowitz as Chairman of Scientific Advisory Board 2Oramed Pharmaceuticals Appoints Dr. Michael Berelowitz as Chairman of Scientific Advisory Board 3VENENUM Biodesign Announces Opening of Medicinal Chemistry Labs 2
(Date:12/17/2014)... Dec. 15, 2014  HITLAB SM announced today its ... confirm its adherence to current U.S. Food and Drug ... regulated smart device and smart phone application trials utilizing ... "HITLAB is determined to improve global healthcare ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ... to their offering. One major trend ... continuous advances in technology, it is important to upgrade ...
(Date:12/10/2014)...  Valencell, a leader in performance biometric data sensor technology, ... its licensees for highly accurate, clinically validated biometric technology. ... from fitness and health sectors, but first responders/military and ... only as useful as the biometric data it delivers. ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... to accurately measure the levels of important chemicals in ... level of a single cell. Scientists at the Carnegie ... the first to overcome this obstacle by successfully applying ... brain chemical levels. The sensors alter their 3-dimensional form ...
... A research team based at Massachusetts General Hospital (MGH) ... of RNA interference (RNAi), a powerful new research tool ... the RNAi process itself to find new genes that ... to fight human disease. The report will appear in ...
... Montreal is pleased to announce the first successful birth in ... Seang Lin Tan, Chair of the Department of Obstetrics and ... Centre at the MUHC in Montreal confirmed the birth of ... are the first in-vitro fertilization (IVF) Centre in Canada to ...
Cached Biology News:Revolutionary nanotechnology illuminates brain cells at work 2Revolutionary nanotechnology illuminates brain cells at work 3Scientists identify genetic pathways essential to RNA interference 2Scientists identify genetic pathways essential to RNA interference 3First frozen egg baby born in Canada 2First frozen egg baby born in Canada 3
... solution, Type I is ... and agarose gel electrophoresis ... offers the advantage of ... blue and xylene cyanole). ...
Rabbit polyclonal to QKI...
... SilverSNAP Stain for Mass Spectrometry Applications ... spectrometry (MS) has emerged as a powerful ... of 2-D gels is now an important ... that leads ultimately to identification of specific ...
... without ammonium sulfate are compatible with thermostable ... Taq and AmpliThem™™ DNA polymerases. You can ... in one experiment by adding your own ... PreMixes supplied with the kit. This capability ...
Biology Products: